By Dave Sebastian
Boston Scientific Corp. said its profit rose for the first quarter as sales increased, including a 10% growth in its cardiovascular sales.
The Marlborough, Mass.-based medical-products company Wednesday posted net income of $341 million, compared with $11 million in the prior year. Earnings were 23 cents a share, compared with a penny a share in the year-ago period.
Adjusted earnings were 37 cents a share. Analysts polled by FactSet were looking for 31 cents a share. The company had guided earnings of 5 cents a share to 11 cents a share, and 28 cents a share to 34 cents a share on an adjusted basis.
Net sales rose 8.2% to $2.75 billion, ahead of its guidance of a flat to 6% growth. Analysts were looking for $2.62 billion.
Write to Dave Sebastian at firstname.lastname@example.org
(END) Dow Jones Newswires
April 28, 2021 06:58 ET (10:58 GMT)Copyright (c) 2021 Dow Jones & Company, Inc.